Suchergebnisse - "Sarilumab"

PubPharm (75)

1

Risk factors for thromboembolic events in patients hospitalized for COVID-19 pneumonia in a general ward and requiring treatment with oxygen

enthalten in: Postgraduate medical journal | 2024

von Degrave, R. | Murris, J. | Charles-Nelson, A. | +10

2

Effect of Anti-Interleukin-6 Agents on Psychopathology in a Sample of Patients with Post-COVID-19 Syndrome : An Observational Study

enthalten in: Brain sciences | 2024

von Simonetti, A. | Restaino, A. | Bernardi, E. | +10

3

Effect of Anti-Interleukin-6 Agents on Psychopathology in a Sample of Patients with Post-COVID-19 Syndrome: An Observational Study

in: Brain Sciences | 2024

von Alessio Simonetti | Antonio Restaino | Evelina Bernardi | +10

4

Efficacy and safety of interleukin-6 receptor antagonists in adult patients admitted to intensive care unit with COVID-19 : A systematic review and meta-analysis of randomized controlled trials

enthalten in: Preventive medicine reports | 2023

von Peng, R. | Yang, T. | Tong, Y. | +7

5

A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19 : a natural experiment due to drug shortages

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Swets, M. | Moss, R. | Kor, F. | +10

6

Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial

enthalten in: Open forum infectious diseases | 2023

von Trigo-Rodríguez, M. | Cárcel, S. | Navas, A. | +21

7

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Gallagher, J. | Morgan, R.

CommentOn: Clin Microbiol Infect. 2023 Jan;29(1):13-21. - PMID 35863630

8

Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids : a systematic review and meta-analysis

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Albuquerque, A. | Eckert, I. | Tramujas, L. | +4

CommentIn: Clin Microbiol Infect. 2023 Jan;29(1):7-9. - PMID 36257548

9

A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages

in: International Journal of Infectious Diseases | 2023

von Maaike C. Swets | Rob J. Moss | Flip Kor | +10

10

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19 : a systematic review and meta-analysis

enthalten in: Emerging microbes & infections | 2022

von Yu, S. | Koh, D. | Choi, M. | +4

1
2
3
4
5
6
7
8
Nächster »
[8]